Annex II Use of Product Characteristics Attributes in Composite SOP Instances (Informative)

Bar coding or RFID tagging of contrast agents, drugs, and devices can facilitate the provision of critical information to the imaging modality, such as the active ingredient, concentration, etc. The Product Characteristics Query SOP Class allows a modality to submit the product bar code (or RFID tag) to an SCP to look up the product type, active substance, size/quantity, or other parameters of the product.

This product information can be included in appropriate attributes of the Contrast/Bolus, Device, or Intervention Modules of the Composite SOP Instances created by the modality. The product information then provides key acquisition context data necessary for the proper interpretation of the SOP Instances.

This annex provides informative information about mapping from the Product Characteristics Module attributes of the Product Characteristics Query to the attributes of Composite IODs included in several Modules.

Within this section, if no Product Characteristics Module source for the attribute value is provided, the modality would need to provide local data entry or user selection from a pick list to fill in appropriate values. Some values may need to be calculated based on user-performed dilution of the product at the time of administration.

II.1 Contrast/Bolus Module

Table II-1 CONTRAST/BOLUS MODULE ATTRIBUTE MAPPING

Contrast/Bolus Module Attribute Name Tag Product Characteristics Module Source
Contrast/Bolus Agent (0018,0010) Product Name (0044,0008) Note: If Product Name is multi-valued, use the first value.
Contrast/Bolus Agent Sequence (0018,0012) --
>Include ‘Code Sequence Macro’ Product Type Code Sequence (0044,0007) >‘Code Sequence Macro’
Contrast/Bolus Route (0018,1040)
Contrast/Bolus Administration Route Sequence (0018,0014)
>Include ‘Code Sequence Macro’
>Additional Drug Sequence (0018,002A)
>Include ‘Code Sequence Macro’
Contrast/Bolus Volume (0018,1041) If contrast is administered without dilution, and using full contents of dispensed product: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A) where:, Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (G-D705, SRT, “Volume”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (ml, UCUM, “ml”)
Contrast/Bolus Start Time (0018,1042)
Contrast/Bolus Stop Time (0018,1043)
Contrast/Bolus Total Dose (0018,1044) If contrast is administered using full contents of dispensed product: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (G-D705, SRT, “Volume”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (ml, UCUM, “ml”)
Contrast Flow Rate (0018,1046)
Contrast Flow Duration (0018,1047)
Contrast/Bolus Ingredient (0018,1048) Product Parameter Sequence (0044,0013) > Concept Code Sequence (0040,A168) > Code Meaning (0008,0104), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (G-C52F, SRT, “Active Ingredient”) Note: Contrast/Bolus Ingredient is a CS VR (16 characters max, upper case), so a conversion from the LO VR is required.
Contrast/Bolus Ingredient Concentration (0018,1049) If contrast is administered without dilution: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (121380, DCM, “Active Ingredient Undiluted Concentration”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (mg/ml, UCUM, “mg/ml”)

II.2 ENHANCED Contrast/Bolus Module

Table II-2 ENHANCED CONTRAST/BOLUS MODULE ATTRIBUTE MAPPING

Enhanced Contrast/Bolus Module Attribute Name Tag Product Characteristics Module Source
Contrast/Bolus Agent Sequence (0018,0012) --
>Include ‘Code Sequence Macro’ Product Type Code Sequence (0044,0007) > ‘Code Sequence Macro’
>Contrast/Bolus Agent Number (0018,9337)
>Contrast/Bolus Administration Route Sequence (0018,0014)
>>Include ‘Code Sequence Macro’
>Contrast/Bolus Ingredient Code Sequence (0018,9338) --
>>Include ‘Code Sequence Macro’ Product Parameter Sequence (0044,0013) > Concept Code Sequence (0040,A168), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (G-C52F, SRT, “Active Ingredient”)
>Contrast/Bolus Volume (0018,1041) If contrast is administered without dilution, and using full contents of dispensed product: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (G-D705, SRT, “Volume”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (ml, UCUM, “ml”)
>Contrast/Bolus Ingredient Concentration (0018,1049) If contrast is administered without dilution: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (121380, DCM, “Active Ingredient Undiluted Concentration”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (mg/ml, UCUM, “mg/ml”)
>Contrast/Bolus Ingredient Opaque (0018,9425) Product Parameter Sequence (0044,0013) > Concept Code Sequence (0040,A168) > Code Meaning (0008,0104), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (121381, DCM, “Contrast/Bolus Ingredient Opaque”) and mapped Code Meaning is “YES” or “NO”.
>Contrast Administration Profile Sequence (0018,9340)
>>Contrast/Bolus Volume (0018,1041) If contrast is administered without dilution, and using full contents of dispensed product: Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (G-D705, SRT, “Volume”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (ml, UCUM, “ml”)
>>Contrast/Bolus Start Time (0018,1042)
>>Contrast/Bolus Stop Time (0018,1043)
>>Contrast Flow Rate (0018,1046)
>>Contrast Flow Duration (0018,1047)

II.3 DEVICE Module

Table II-3 DEVICE MODULE ATTRIBUTE MAPPING

Device Module Attribute Name Tag Product Characteristics Module Source
Device Sequence (0050,0010) --
>Include ‘Code Sequence Macro’ Product Type Code Sequence (0044,0007) > ‘Code Sequence Macro’
>Device Length (0050,0014) Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (G-A22A, SRT, “Length”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (mm, UCUM, “mm”)
>Device Diameter (0050,0016) Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (M-02550, SRT, “Diameter”)
>Device Diameter Units (0050,0017) Product Parameter Sequence (0044,0013) > Measurement Units Code Sequence (0040,08EA) > Code Meaning (0008,0104), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (M-02550, SRT, “Diameter”) Note: Device Diameter Units is a CS VR (16 characters max, upper case), so a conversion from the LO VR is required.
>Device Volume (0050,0018) Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (G-D705, SRT, “Volume”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (ml, UCUM, “ml”)
>Inter-Marker Distance (0050,0019) Product Parameter Sequence (0044,0013) > Numeric Value (0040,A30A), where: Product Parameter Sequence > Concept Name Code Sequence (0040,A043) value is (121208, DCM, “Inter-Marker Distance”) and Product Parameter Sequence > Measurement Units Code Sequence (0040,08EA) is (mm, UCUM, “mm”)
>Device Description (0050,0020) Product Name (0044,0008) and/or Product Description (0044,0009)

II.4 INTERVENTION Module

Table II-4 INTERVENTION MODULE ATTRIBUTE MAPPING

Intervention Module Attribute Name Tag Product Characteristics Module Source
Intervention Sequence (0018,0036)
>Include ‘Code Sequence Macro’
>Intervention Status (0018,0038)
>Intervention Drug Code Sequence (0018,0029) --
>>Include ‘Code Sequence Macro’ Product Type Code Sequence (0044,0007) > ‘Code Sequence Macro’
>Intervention Drug Start Time (0018,0035)
>Intervention Drug Stop Time (0018,0027)
> Administration Route Code Sequence (0054,0302)
>>Include ‘Code Sequence Macro’
>Intervention Description (0018,003A)